With over 15 years of experience in the field of cell and gene therapies, Dr. Clarke brings a wealth of expertise to Discovery. He is currently the acting chair for the Process and Product Development Committee of the International Society for Cell and Gene Therapies (ISCT) – a global forum that provides leadership to the industry by guiding the translation of research and process development from laboratory to clinical settings through education and guidance. Prior to joining Discovery, Dr. Clarke held the position of Global Head of Cell Therapy at HemaCare, a Charles River company. During his tenure, he played a key role in developing and implementing the company’s global cell therapy corporate strategy, providing scientific and technical expertise both operationally and commercially, and driving innovation throughout the organization.